Clinical Trials Directory

Trials / Unknown

UnknownNCT02205580

Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Tonsillectomy or Adeno-tonsillectomy in Children

Comparison of Three Different Rates of Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Coblation Tonsillectomy or Adeno-tonsillectomy in Children

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Jin Ni · Academic / Other
Sex
All
Age
5 Years – 8 Years
Healthy volunteers
Not accepted

Summary

Postoperative pain following tonsillectomy or adeno-tonsillectomy in children is severe and sometimes last for days. Sufentanil is used by epidural route for postoperative analgesia in children. There are few reports about its use for postoperative analgesia by continuous intravenous infusion. Its complications include , hypoxia, sedation, pruritus ,nausea and/or vomiting. The investigators design this protocol to test efficacy of analgesia of three different rates of continuous intravenous sufentanil infusion for postoperative pain management following coblation tonsillectomy or adeno-tonsillectomy in children. The investigators also compare incidence rate of complications for three groups.

Conditions

Interventions

TypeNameDescription
DRUGcontinuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion
DRUGcontinuous intravenous sufentanil 0.03μg•kg-1•h-1 infusion
DRUGcontinuous intravenous sufentanil 0.04μg•kg-1•h-1 infusion

Timeline

Start date
2014-09-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2014-07-31
Last updated
2014-09-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02205580. Inclusion in this directory is not an endorsement.

Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Tonsillectomy or Adeno-tonsillect (NCT02205580) · Clinical Trials Directory